Medicare Enrolled
Dr. Jonathan Edwards, M.D.
Family Medicine · Athens, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Edwards from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Edwards? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Edwards
Dr. Jonathan Edwards is a family medicine in Athens, TX, with 19 years in practice. Based on federal Medicare data, Dr. Edwards performed 10,952 Medicare services across 3,953 unique beneficiaries.
Between the years covered by Open Payments, Dr. Edwards received a total of $1,077 from 27 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Edwards is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $1,077 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,952
Medicare services
Top 1% in TX for family medicine
3,953
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~576 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 1,620 | $0 | $6 |
| Nursing facility visit, moderate complexity | 1,574 | $78 | $175 |
| Allergy skin test | 1,053 | $3 | $12 |
| Allergy immunotherapy preparation | 931 | $11 | $22 |
| Office visit, established patient (30-39 min) | 787 | $83 | $176 |
| Office visit, established patient (20-29 min) | 529 | $59 | $182 |
| Nursing facility visit, low complexity | 353 | $51 | $148 |
| Blood draw (venipuncture) | 352 | $8 | $19 |
| Home visit, established patient, moderate complexity | 286 | $96 | $150 |
| Drug injection, under skin or into muscle | 274 | $9 | $37 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 269 | $15 | $77 |
| Home visit, established patient, low complexity | 175 | $57 | $105 |
| Hospital follow-up visit, moderate complexity | 170 | $60 | $197 |
| Hospital discharge management, 30+ min | 145 | $87 | $290 |
| Critical care, first 30-74 min | 143 | $163 | $425 |
| Annual wellness visit, follow-up | 136 | $122 | $175 |
| Automated urinalysis | 132 | $2 | $22 |
| Exam of neurobehavioral status, first hour | 108 | $66 | $175 |
| Ceftriaxone antibiotic injection | 102 | $0 | $14 |
| Annual depression screening | 97 | $18 | $50 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 97 | $25 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 94 | $22 | $75 |
| Injection, methylprednisolone acetate, 40 mg | 94 | $5 | $26 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 91 | $134 | $200 |
| Hospital follow-up visit, high complexity | 89 | $91 | $283 |
| Injection, ketorolac tromethamine, per 15 mg | 80 | $0 | $14 |
| Critical care, each additional 30 minutes | 71 | $82 | $200 |
| Urinalysis, manual | 70 | $3 | $20 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 69 | $31 | $70 |
| Electrocardiogram (EKG), 12-lead | 67 | $9 | $76 |
| Transitional care management services for problem of at least moderate complexity | 66 | $152 | $265 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | 63 | $98 | $100 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 59 | $38 | $139 |
| Initial hospital admission, high complexity | 56 | $130 | $557 |
| Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | 55 | $28 | $53 |
| Transitional care management services for problem of high complexity | 54 | $207 | $394 |
| Office visit, established patient, complex (40-54 min) | 52 | $132 | $317 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 47 | $47 | $150 |
| New patient office visit (30-44 min) | 41 | $48 | $153 |
| Advance care planning consultation, first 30 min | 41 | $58 | $151 |
| Initial hospital admission, moderate complexity | 36 | $93 | $238 |
| Flu vaccine administration | 35 | $29 | $31 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 28 | $113 | $200 |
| Administration of vaccine | 26 | $14 | $30 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 25 | $20 | $35 |
| Ultrasound study of arm and leg arteries | 25 | $60 | $165 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 24 | $41 | $192 |
| Test to measure expiratory airflow and volume | 24 | $20 | $77 |
| Flu vaccine, quadrivalent | 23 | $75 | $81 |
| New patient office or other outpatient visit, 15-29 minutes | 22 | $51 | $143 |
| Inhalation treatment for airway obstruction or sputum production | 21 | $6 | $49 |
| New patient office visit (45-59 min) | 20 | $80 | $211 |
| Removal of impacted ear wax | 19 | $26 | $83 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 18 | $96 | $140 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $245 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
20.0% medium
78.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,077
Total received (2018-2024)
Avg $154/year across 7 years
Top 37% in TX for family medicine
27
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$927 (86.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$150 (13.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$163
2023$87
2022$144
2021$151
2020$285
2019$99
2018$147
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Galderma Laboratories, L.P.
$150
Astellas Pharma US Inc
$106
Vanda Pharmaceuticals Inc.
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
Mylan Specialty L.P.
$64
Otsuka America Pharmaceutical, Inc.
$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Novo Nordisk Inc
$58
Amgen Inc.
$49
Biohaven Pharmaceutical Holding Company Ltd.
$36
Amneal Pharmaceuticals LLC
$33
ITI, Inc.
$32
Pharmacyclics LLC, An AbbVie Company
$30
Takeda Pharmaceuticals U.S.A., Inc.
$26
Novartis Pharmaceuticals Corporation
$23
Teva Pharmaceuticals USA, Inc.
$19
ABBVIE INC.
$19
Ironshore Pharmaceuticals Inc.
$18
Biogen, Inc.
$16
Indivior Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Dexcom, Inc.
$13
Lilly USA, LLC
$13
Merck Sharp & Dohme LLC
$13
AbbVie Inc.
$12
Sanofi Pasteur Inc.
$11
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 31.8% of total payments
Associated products mentioned in payments ›
ADUHELM · AUSTEDO · BASAGLAR · CAPLYTA · Dexcom G6 Transmitter · Dymista · ENTRESTO · EPKINLY · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · HETLIOZ · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · MYRBETRIQ · NURTEC ODT · OFEV · Otezla · Ozempic · PRADAXA · REXULTI · RYTARY · Rybelsus · SUBLOCADE · Trintellix · VRAYLAR · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
37
Per 100K population
44.2
County median income
$63,955
Nearest hospital
UT HEALTH EAST TEXAS ATHENS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Edwards is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Edwards experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Edwards performed 1,620 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Edwards receive payments from pharmaceutical companies?
Yes. Dr. Edwards received a total of $1,077 from 27 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Edwards's costs compare to other family medicines in Athens?
Dr. Edwards's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Edwards) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Athens
Browse family medicines in Athens ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P..
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Vanda Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Vanda Pharmaceuticals Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology